LLY News and Press, Eli Lilly and Company From 01/25/24

2024-01-25 11:28:40 ET More on S&P 500 Index: The Most Important New All-Time High Has Yet To Be Achieved Fed Preview: Expect Interest Rate Cuts In May, June, November And December Attention Turns To Lagarde's Press Conference And U.S. Q4 GDP Tractor Supp...

Johna Norton to Retire as Lilly Executive Vice President of Global Quality PR Newswire INDIANAPOLIS , Jan. 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Johna Norton , executive vice president of Global Quality, will be retir...

2024-01-25 08:00:00 ET Summary Alex Carchidi calls the biotech sector highly risky and speculative, and says diversification is key for investors. Funding is currently difficult to obtain in the biotech industry, but a turnaround is expected. Competitive stories in gene editin...

2024-01-25 06:35:07 ET Eli Lilly's ( NYSE: LLY ) diabetes drug Mounjaro, in 12.5mg dose, has limited availability in the U.S. through February 2024, due to an increase in demand.... Read the full article on Seeking Alpha For further details see: Eli Lilly's Mounjaro ...

2024-01-24 14:16:06 ET More on Eli Lilly Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly: The Buzz Is Not Over Eli Lilly and Company (LLY) JPMorgan 42nd Annual Healthcare Conference Eli Lilly production plant said to be under renewed FDA scrutiny L...

2024-01-24 14:10:07 ET More on S&P 500 Index: Bullard Says A March Rate Cut Looks Prudent PBOC Cuts Reserve Requirements, But USD Pullback May Offer New Buying Opportunity In North America SPY: Black Swan Hiding In Plain Sight Tractor Supply is the most s...

2024-01-23 17:10:35 ET Summary Merus N.V. shares have remained strong despite negative safety news about its MCLA-129 program, as attention shifts to promising candidates petosemtamab and zenocutuzumab. Petosemtamab shows solid overall response rates for head and neck cancer, whil...

Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting PR Newswire Hearing restoration was observed within 30 days of a single administration o...

Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance PR Newswire INDIANAPOLIS , Jan. 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2023 financial results a...

2024-01-23 01:59:00 ET Eli Lilly (NYSE: LLY) is a highly successful business, and as with any big corporate success story, some critics will offer a counter-narrative of stagnation and decay lurking in the background. However, frequently enough, such bearish overtures are missing ke...